IMRIS, Monteris & MRI Interventions
sponsoring luncheon seminar
MINNEAPOLIS and IRVINE, CA, April 15,
2015 /PRNewswire/ - Three prominent neurosurgeons will
review their clinical experience using real-time navigated laser
therapy for brain lesion ablation within intraoperative MRI suites
at the upcoming 83rd American Association of
Neurological Surgeons (AANS) Annual Scientific Meeting. IMRIS Inc.
(NASDAQ: IMRS; TSX: IM) ("IMRIS"), MRI Interventions, Inc. (OTCQB:
MRIC), and Monteris Medical Inc. today jointly announced that the
companies are sponsoring the Lunch and Learn seminar scheduled for
1:15-2:00 p.m. on Monday, May 4.
The panel will review workflow and results using Monteris'
NeuroBlate® System, a minimally invasive robotic laser
thermotherapy tool, coupled with MRI Interventions'
ClearPoint® navigation system providing precise
targeting for procedures conducted within an IMRIS
VISIUS® Surgical Theatre with intraoperative MRI
(iMRI).
Veronica L.S. Chiang, M.D. of
Yale-New Haven Hospital, New Haven,
Conn., will lead the discussion with panelists John Honeycutt, M.D. of Cook Children's
Hospital, Fort Worth, Texas; and
Eric C. Leuthardt, M.D. of
Barnes-Jewish Hospital, St. Louis,
Mo.
The NeuroBlate System employs a pulsed surgical laser to deliver
targeted energy to abnormal brain tissue such as tumors and other
neurological soft tissue lesions through a minimally invasive and
image-guided approach.
The ClearPoint system, the only neuro-navigation technology that
enables minimally-invasive neurosurgery under continuous magnetic
resonance (MR) guidance, provides surgeons with a high-resolution
view of the patient's brain and real-time direction during
intracranial procedures.
The VISIUS Surgical Theatre allows use of the highest quality MR
in the operating room – instead of a radiology or diagnostic room –
and over the OR table by moving it to the patient with
ceiling-mounted rails. The fully integrated suites allow the
scanner to move between multiple rooms, providing on-demand access
to high resolution MR images – before, during and after procedures,
without moving the patient.
The AANS Annual Scientific Meeting is one of the largest
gatherings of neurological clinicians. More information about the
luncheon and other AANS events is available on the society's
website: http://www.aans.org/annualmeeting.aspx. Learn more about
IMRIS, MRI Interventions and Monteris by visiting the companies'
websites.
About IMRIS
IMRIS (NASDAQ: IMRS; TSX: IM) is a
global leader in providing image guided therapy solutions through
its VISIUS Surgical Theatre – a revolutionary, multifunctional
surgical environment that provides unmatched intraoperative vision
to clinicians to assist in decision making and enhance precision in
treatment. The multi-room suites incorporate diagnostic quality
high-field MR, CT and angio modalities accessed effortlessly in the
operating room setting. VISIUS Surgical Theatres serve the
neurosurgical, spinal, cardiovascular and cerebrovascular markets
and have been selected by leading medical institutions around the
world. Learn more by visiting www.imris.com.
About Monteris
Monteris Medical is a privately held
company developing devices for minimally-invasive, MR-guided
neurosurgery. Monteris markets the NeuroBlate® System for
controlled, volumetric ablation of brain lesions. Monteris also
offers the various Stereotactic anchoring devices for image-guided
trajectory alignment, and the AtamA™ Stabilization System for MR
based procedures requiring versatile head fixation. Now
headquartered in Minneapolis,
Minnesota, Monteris was founded in Winnipeg, Manitoba, and maintains a
significant portion of its staff and operations there. For more
information on Monteris Medical please visit
www.monteris.com.
About MRI Interventions, Inc.
Building on the
imaging power of MRI, MRI Interventions is creating innovative
platforms for performing the next generation of minimally invasive
surgical procedures in the brain and heart. The company's
ClearPoint® system utilizes a hospital's existing diagnostic or
intraoperative MRI scanner to enable a range of minimally invasive
procedures in the brain. In partnership with Siemens
Healthcare, MRI Interventions is developing the ClearTrace® system
to enable MRI-guided catheter ablations to treat cardiac
arrhythmias. For more information, please visit
www.mriinterventions.com.
SOURCE IMRIS Inc.
